Articles by David Ingram, Reuters

We found 1 results.


GlaxoSmithKline Settles Healthcare Fraud Case for $3 Billion
David Ingram, Reuters – TRANSCEND Media Service, 9 Jul 2012

GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday [2 Jul 2012] described as the largest case of healthcare fraud in U.S. history. GSK targeted the antidepressant Paxil to patients under age 18 when it was approved for adults only, and it pushed the drug Wellbutrin for uses it was not approved for.

→ read full article